The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

PTGX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Protagonist Therapeutics Insider Trading History Chart

Protagonist Therapeutics Share Price & Price History

^$16.68

▼ -0.45 (-2.63%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Free Stock Analysis Report: See The True Value of Any Stock

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

Protagonist Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/21/2021	Dinsesh V. Patel	CEO	Sell	15,000	$32.14	$482,100.00
8/17/2021	David Y. Liu	Insider	Sell	14,779	$47.56	$702,889.24
2/10/2021	Sarah B Noonberg	Director	Sell	4,700	$25.47	$119,709.00	4,700
1/19/2021	Dinsesh V. Patel	CEO	Sell	24,846	$24.60	$611,211.60	450,990

This Stock Could Go Up 66% or More.

From Chaikin Analytics | Ad

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

More here.

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

98.63% of Protagonist Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protagonist Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/24/2023	Perceptive Advisors LLC	1,469,761	$40.60M	1.2%	+52.3%	2.555%
8/21/2023	California State Teachers Retirement System	57,648	$1.59M	0.0%	+16.0%	0.100%
8/16/2023	Nuveen Asset Management LLC	935,961	$25.85M	0.0%	+13.0%	1.627%
8/15/2023	Alliancebernstein L.P.	80,200	$2.22M	0.0%	+48.0%	0.139%
8/15/2023	Wells Fargo & Company MN	71,051	$1.96M	0.0%	+109.2%	0.124%
8/15/2023	Eventide Asset Management LLC	320,000	$8.84M	0.1%	N/A	0.556%
8/15/2023	Woodline Partners LP	427,264	$11.80M	0.1%	-30.9%	0.743%
8/15/2023	Goldman Sachs Group Inc.	559,210	$15.45M	0.0%	+21.7%	0.972%
8/15/2023	Zacks Investment Management	10,952	$0.30M	0.0%	-7.7%	0.019%
8/15/2023	Readystate Asset Management LP	204,880	$5.66M	0.4%	N/A	0.356%
8/15/2023	Royal Bank of Canada	4,217	$0.12M	0.0%	+60.1%	0.007%
8/15/2023	Seven Eight Capital LP	27,092	$0.75M	0.1%	N/A	0.047%
8/15/2023	Silverarc Capital Management LLC	25,000	$0.69M	0.2%	-76.3%	0.043%
8/15/2023	Suvretta Capital Management LLC	81,143	$2.24M	0.1%	N/A	0.141%
8/15/2023	HighVista Strategies LLC	29,179	$0.81M	0.4%	N/A	0.051%
8/15/2023	Holocene Advisors LP	802,531	$22.17M	0.1%	N/A	1.395%
8/15/2023	Kennedy Capital Management LLC	403,648	$11.15M	0.3%	+21.8%	0.702%
8/15/2023	Kynam Capital Management LP	975,298	$26.94M	3.7%	-29.1%	1.695%
8/15/2023	Bayesian Capital Management LP	9,211	$0.25M	0.0%	N/A	0.016%
8/14/2023	683 Capital Management LLC	814,000	$22.48M	1.6%	-6.8%	1.415%
8/14/2023	Cormorant Asset Management LP	1,500,000	$41.43M	2.3%	-11.8%	2.607%
8/14/2023	Tudor Investment Corp Et Al	33,338	$0.92M	0.0%	-10.7%	0.058%
8/14/2023	Tower Research Capital LLC TRC	3,118	$86K	0.0%	+88.1%	0.005%
8/14/2023	Marshall Wace LLP	164,500	$4.54M	0.0%	-88.0%	0.286%
8/14/2023	State of Wisconsin Investment Board	49,677	$1.37M	0.0%	+37.3%	0.086%
8/14/2023	Artia Global Partners LP	112,340	$3.10M	1.1%	N/A	0.195%
8/14/2023	State Street Corp	3,551,986	$98.11M	0.0%	+47.2%	6.174%
8/14/2023	Jefferies Financial Group Inc.	760,561	$21.01M	0.2%	N/A	1.322%
8/14/2023	Capital Fund Management S.A.	26,605	$0.74M	0.0%	N/A	0.046%
8/14/2023	Nuveen Asset Management LLC	935,961	$25.85M	0.0%	+13.0%	1.627%
8/14/2023	Ghisallo Capital Management LLC	50,000	$1.38M	0.2%	N/A	0.087%
8/14/2023	Silvercrest Asset Management Group LLC	128,197	$3.54M	0.0%	+13.1%	0.223%
8/14/2023	Thrivent Financial for Lutherans	73,381	$2.03M	0.0%	-27.3%	0.128%
8/11/2023	Renaissance Technologies LLC	390,267	$10.78M	0.0%	-43.5%	0.678%
8/11/2023	Credit Suisse AG	62,834	$1.74M	0.0%	+65.3%	0.109%
8/11/2023	BlackRock Inc.	5,009,273	$138.36M	0.0%	+13.8%	8.707%
8/11/2023	Ameritas Investment Partners Inc.	4,477	$0.12M	0.0%	+27.9%	0.008%
8/11/2023	Harvest Investment Services LLC	44,113	$1.22M	0.7%	N/A	0.077%
8/11/2023	Campbell & CO Investment Adviser LLC	20,558	$0.57M	0.1%	N/A	0.036%
8/11/2023	State Board of Administration of Florida Retirement System	15,393	$0.43M	0.0%	+35.9%	0.027%
8/11/2023	The Manufacturers Life Insurance Company	65,892	$1.82M	0.0%	+46.9%	0.115%
8/11/2023	Hsbc Holdings PLC	560,455	$15.65M	0.0%	N/A	0.974%
8/11/2023	Franklin Resources Inc.	41,084	$1.14M	0.0%	+26.3%	0.071%
8/11/2023	Trexquant Investment LP	11,413	$0.32M	0.0%	N/A	0.020%
8/11/2023	Geode Capital Management LLC	1,077,184	$29.75M	0.0%	+16.3%	1.872%
8/11/2023	Artal Group S.A.	500,000	$13.81M	0.4%	N/A	0.869%
8/11/2023	Sei Investments Co.	72,016	$1.99M	0.0%	+102.1%	0.125%
8/11/2023	E Fund Management Co. Ltd.	15,354	$0.42M	0.0%	+76.2%	0.027%
8/11/2023	Northern Trust Corp	538,125	$14.86M	0.0%	+27.3%	0.935%
8/11/2023	ExodusPoint Capital Management LP	14,654	$0.41M	0.0%	N/A	0.025%
8/10/2023	MetLife Investment Management LLC	28,596	$0.79M	0.0%	+19.6%	0.050%
8/10/2023	ProShare Advisors LLC	10,755	$0.30M	0.0%	+21.0%	0.019%
8/10/2023	Profund Advisors LLC	51,783	$1.43M	0.1%	+79.8%	0.090%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	35,667	$0.99M	0.0%	+29.1%	0.062%
8/10/2023	Great Lakes Advisors LLC	147,048	$4.06M	0.0%	-2.3%	0.256%
8/10/2023	Russell Investments Group Ltd.	43,522	$1.20M	0.0%	-56.5%	0.076%
8/10/2023	Charles Schwab Investment Management Inc.	419,610	$11.59M	0.0%	+16.2%	0.729%
8/10/2023	Citigroup Inc.	107,521	$2.97M	0.0%	-50.6%	0.187%
8/9/2023	Dimensional Fund Advisors LP	1,039,105	$28.70M	0.0%	-17.7%	1.806%
8/9/2023	BNP Paribas Arbitrage SNC	202,310	$5.59M	0.0%	-14.9%	0.352%
8/9/2023	TD Asset Management Inc	55,400	$1.53M	0.0%	+91.0%	0.096%
8/9/2023	Swiss National Bank	98,000	$2.71M	0.0%	+23.0%	0.170%
8/8/2023	Rhumbline Advisers	77,911	$2.15M	0.0%	+4.3%	0.136%
8/8/2023	Candriam S.C.A.	725,000	$20.02M	0.1%	+16.0%	1.266%
8/8/2023	International Biotechnology Trust PLC	19,900	$0.55M	0.2%	N/A	0.035%
8/7/2023	Cowen AND Company LLC	1,657,551	$45.78M	3.8%	N/A	2.895%
8/7/2023	Obermeyer Wood Investment Counsel Lllp	12,612	$0.35M	0.0%	-7.9%	0.022%
8/4/2023	American International Group Inc.	26,094	$0.72M	0.0%	+16.2%	0.046%
8/3/2023	Los Angeles Capital Management LLC	9,366	$0.26M	0.0%	-79.4%	0.016%
8/3/2023	Barclays PLC	193,439	$5.34M	0.0%	-66.9%	0.336%
8/3/2023	Mackenzie Financial Corp	12,745	$0.28M	0.0%	-53.7%	0.022%
8/3/2023	Bank of New York Mellon Corp	199,575	$5.51M	0.0%	+18.4%	0.349%
8/3/2023	Gratus Capital LLC	219,586	$6.07M	0.4%	+3.7%	0.384%
8/2/2023	Bank of Montreal Can	310,000	$8.68M	0.0%	N/A	0.541%
8/1/2023	Arizona State Retirement System	12,645	$0.35M	0.0%	+18.3%	0.022%
7/31/2023	Strs Ohio	23,700	$0.65M	0.0%	N/A	0.041%
7/28/2023	Moody Aldrich Partners LLC	41,860	$1.16M	0.2%	N/A	0.073%
7/24/2023	Allspring Global Investments Holdings LLC	175,529	$4.85M	0.0%	-21.5%	0.307%
7/19/2023	Teacher Retirement System of Texas	12,214	$0.34M	0.0%	+7.5%	0.021%
7/18/2023	Allspring Global Investments Holdings LLC	175,529	$4.85M	0.0%	-21.5%	0.307%
7/10/2023	SG Americas Securities LLC	195,756	$5.41M	0.0%	+957.3%	0.342%
5/26/2023	ProShare Advisors LLC	8,886	$0.20M	0.0%	N/A	0.016%
5/22/2023	Ameriprise Financial Inc.	18,358	$0.42M	0.0%	N/A	0.032%
5/18/2023	JPMorgan Chase & Co.	106,133	$2.44M	0.0%	-65.0%	0.185%
5/17/2023	Financial Enhancement Group LLC	41,818	$1.06M	0.2%	N/A	0.073%
5/16/2023	Perceptive Advisors LLC	965,152	$22.20M	0.7%	N/A	1.686%
5/16/2023	Silvercrest Asset Management Group LLC	113,355	$2.61M	0.0%	-52.9%	0.198%
5/16/2023	State Street Corp	2,413,701	$55.52M	0.0%	-36.4%	4.216%
5/16/2023	Fred Alger Management LLC	11,605	$0.27M	0.0%	N/A	0.020%
5/16/2023	Geode Capital Management LLC	925,993	$21.30M	0.0%	+5.2%	1.617%
5/16/2023	BVF Inc. IL	3,775,900	$86.85M	3.2%	N/A	6.595%
5/15/2023	Schonfeld Strategic Advisors LLC	148,992	$3.43M	0.0%	N/A	0.260%
5/15/2023	Cubist Systematic Strategies LLC	64,978	$1.49M	0.0%	+26.2%	0.113%
5/15/2023	Two Sigma Advisers LP	449,800	$10.35M	0.0%	-25.5%	0.786%
5/15/2023	Two Sigma Investments LP	307,700	$7.08M	0.0%	-37.5%	0.537%
5/15/2023	Deutsche Bank AG	958,891	$22.05M	0.0%	+3.6%	1.675%
5/15/2023	Price T Rowe Associates Inc. MD	415,274	$9.55M	0.0%	N/A	0.725%
5/15/2023	RTW Investments LP	4,600,799	$105.82M	2.2%	+28.1%	8.036%
5/15/2023	AXA S.A.	86,500	$1.99M	0.0%	-19.7%	0.151%
5/15/2023	Ghost Tree Capital LLC	225,000	$5.18M	1.5%	N/A	0.393%

Data available starting January 2016

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of erythrocytosis, iron overload, and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that is in Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist, which is in Phase II clinical trials for inflammatory bowel disease. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Today's Range

Now: $16.68

$16.33

$17.31

50 Day Range

MA: $18.76

$16.68

$20.37

52 Week Range

Now: $16.68

$7.24

$30.10

Volume

1,388,445 shs

Average Volume

652,208 shs

Market Capitalization

$959.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Protagonist Therapeutics?: Protagonist Therapeutics' top insider investors include:
Dinesh V Ph D Patel (CEO)
Learn More about top insider investors at Protagonist Therapeutics.